Medicare Enrolled

Dr. Tetyana Roytman, FNP

Nurse Practitioner - Family · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1117 BRIGHTON BEACH AVE, Brooklyn, NY 11235
7189989900
In practice since 2019 (6 years)
NPI: 1982249868 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Roytman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roytman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Roytman

Dr. Tetyana Roytman is a nurse practitioner - family in Brooklyn, NY, with 6 years of NPI registration. Based on federal Medicare data, Dr. Roytman performed 2,133 Medicare services across 1,190 unique beneficiaries.

Between the years covered by Open Payments, Dr. Roytman received a total of $5,377 from 37 pharmaceutical and/or device companies across 267 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Roytman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice ▲ Top 4% volume in NY $5,377 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,133
Medicare services
Top 4% in NY for nurse practitioner - family
1,190
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~356 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
562 $68 $107
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
343 $29 $46
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
332 $1 $34
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
156 $11 $17
Injection, thiamine hcl, 100 mg 141 $2 $77
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
127 $1 $35
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
106 $12 $19
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
60 $94 $151
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
42 $0 $41
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
36 $78 $117
Head repositioning exercises for dizziness
A series of exercises performed to reposition the head, used to treat dizziness. The procedure is administered on a daily basis.
31 $34 $54
Vestibular function test with thermal irrigation
A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function.
28 $31 $47
Balance testing with recording
A procedure to evaluate balance function by recording the results during testing.
28 $84 $127
Use of electrodes during balance testing
Application of electrodes to monitor physiological responses during a balance assessment.
28 $10 $13
Vestibular function test using rotating chair
This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability.
25 $103 $155
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
18 $166 $250
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
17 $46 $75
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $132 $198
Lidocaine HCl injection for IV infusion, 10 mg
Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion.
14 $0 $27
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $79 $135
Injection, methylprednisolone acetate, 40 mg 12 $6 $28
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
59.8% medium
39.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,377
Total received (2021-2024)
Avg $1,344/year across 4 years
Top 4% in NY for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
267
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,377 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$817
2023
$1,835
2022
$1,352
2021
$1,373

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$282
SK Life Science, Inc.
$125
Eisai Inc.
$71
HARMONY BIOSCIENCES LLC
$68
Azurity Pharmaceuticals, Inc.
$61
UCB, Inc.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$35
Neurocrine Biosciences, Inc.
$26
Kyowa Kirin, Inc.
$25
PFIZER INC.
$22
Lilly USA, LLC
$21
Otsuka America Pharmaceutical, Inc.
$19
Lundbeck LLC
$17
Top 3 companies account for 58.5% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$923
UCB, Inc.
$603
SK Life Science, Inc.
$398
Allergan, Inc.
$338
Biogen, Inc.
$276
Neurocrine Biosciences, Inc.
$249
Azurity Pharmaceuticals, Inc.
$244
Scilex Pharmaceuticals Inc.
$209
Harmony Biosciences LLC
$205
Lilly USA, LLC
$204
Arbor Pharmaceuticals, Inc.
$202
ARBOR PHARMACEUTICALS, INC.
$164
Otsuka America Pharmaceutical, Inc.
$150
Amneal Pharmaceuticals LLC
$144
Neurelis, Inc.
$94
Eisai Inc.
$92
Lundbeck LLC
$89
Avanir Pharmaceuticals, Inc.
$86
Sunovion Pharmaceuticals Inc.
$81
Takeda Pharmaceuticals U.S.A., Inc.
$78
HARMONY BIOSCIENCES LLC
$68
SCILEX PHARMACEUTICALS INC.
$62
Teva Pharmaceuticals USA, Inc.
$59
Sumitomo Pharma America, Inc.
$46
AbbVie Inc.
$44
GENZYME CORPORATION
$40
Amgen Inc.
$25
EISAI INC.
$25
Kyowa Kirin, Inc.
$25
Genentech USA, Inc.
$23
PFIZER INC.
$22
Biohaven Pharmaceutical Holding Company Ltd.
$21
Bausch Health US, LLC
$20
Alexion Pharmaceuticals, Inc.
$20
Boston Scientific Corporation
$16
Kowa Pharmaceuticals America, Inc.
$16
Supernus Pharmaceuticals, Inc.
$15
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
AJOVY · AMYVID · APLENZIN · APTIOM · AUBAGIO · Aimovig · Austedo XR · BOTOX · Briviact · DUOPA · EMGALITY · Eprontia · Fycompa · HORIZANT · HYQVIA · Horizant · INGREZZA · Leqembi · NUEDEXTA · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONGENTYS · OXTELLAR XR · Ocrevus · QULIPTA · REXULTI · RYTARY · SEGLENTIS · Soliris · TRINTELLIX · TYSABRI · UBRELVY · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · WAKIX · WATCHMAN Access System · Wakix · XCOPRI · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for nurse practitioner - family in NY.

Looking for a nurse practitioner - family in Brooklyn?
Compare family nurse practitioners in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
7,196
Per 100K population
271.9
County median income
$78,548
Nearest hospital
SOUTH BROOKLYN HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Roytman is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NY), with low-engagement industry engagement in the top 4% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Roytman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Roytman performed 562 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Roytman receive payments from pharmaceutical companies?
Yes. Dr. Roytman received a total of $5,377 from 37 companies across 267 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roytman's costs compare to other family nurse practitioners in Brooklyn?
Dr. Roytman's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roytman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →